Role of IL12 as an anti-tumour agent: current status and future directions

This publication has 14 references indexed in Scilit:

• AK-5 Tumor-Induced Expression of Interleukin-12: Role of IL-12 in NK-Mediated AK-5 Regression
  Cellular Immunology, 1995
• Inhibition of Angiogenesis In Vivo by Interleukin 12
  JNCI Journal of the National Cancer Institute, 1995
• Role of Interferon-γ in Mediating the Antitumor Efficacy of Interleukin-12
  Journal of Immunotherapy, 1995
• CD4 T cells inhibitin vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes
  European Journal of Immunology, 1995
• Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes
  Blood, 1994
• Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach.
  Journal of Clinical Investigation, 1994
• Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo
  International Immunology, 1994
• Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies
  Blood, 1993
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
  The Journal of Experimental Medicine, 1993
• The Molecular Cell Biology of Interferon-gamma and its Receptor
  Annual Review of Immunology, 1993